- Clinical Trials
- April 2024
- 60 Pages
Global
From €1910EUR$2,000USD£1,597GBP
- Report
- October 2024
- 81 Pages
Global
From €3500EUR$3,926USD£3,029GBP
- Report
- May 2022
- 40 Pages
Global
From €1910EUR$2,000USD£1,597GBP
The Arterial Thrombosis Drug market is a subset of the Cardiovascular Drugs market, which focuses on the treatment of arterial thrombosis. Arterial thrombosis is a condition in which a blood clot forms in an artery, blocking the flow of blood to the heart, brain, or other organs. Arterial thrombosis drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular events. These drugs work by preventing the formation of blood clots, or by dissolving existing clots. Commonly used drugs include anticoagulants, antiplatelet agents, and thrombolytics.
Some companies in the Arterial Thrombosis Drug market include Bayer, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. Show Less Read more